Teenager Survives Emergency Transplant Surgery and Blood Clot in Brain
‘Half-Match’ Bone Marrow Transplants Cure Sickle Cell in Trial
Researchers conducting a trial have found that a bone marrow transplant from a donor who is only half-matched genetically can cure sickle cell.
Plan to boost organ donor rate – Tasmania Mercury
Tasmania MercuryPlan to boost organ donor rateTasmania MercuryMr Mulder said yesterday a simple policy switch from an opt-in organ donation to opt-out organ donation could save another 1800 Australian lives every year. "Australia has an opt-in sys…
Donor stems cells may help heart failure – UPI.com
Donor stems cells may help heart failureUPI.comThe study, published in the Journal of the American Medical Association and presented at the American Heart Association's Scientific Sessions, found heart failure improved in 28 percent of those receiv…
Pfizer resolving several lawsuits over its drugs
Drugmaker Pfizer Inc. expects to pay about $825 million to resolve government and civil lawsuits involving numerous medicines, according to a filing with regulators.
Naperville resident researching critical component in heart failure – Naperville Sun
Naperville resident researching critical component in heart failureNaperville Sun“I'm particularly interesting in curing and preventing heart failure,” he says. An assistant professor at Loyola University Chicago Stritch School of Medicine, Sad…
Rituxan Turns in Good Safety Profile in RA – MedPage Today
Rituxan Turns in Good Safety Profile in RAMedPage TodayWASHINGTON — Serious infectious events associated with rituximab (Rituxan) remain consistently low in rheumatoid arthritis (RA) patients for nearly a decade after first treatment, researchers said…
Cyclosporine Supply 50ml 100mg/ml oral solution to Hospital del Salvador … – Equities.com
Cyclosporine Supply 50ml 100mg/ml oral solution to Hospital del Salvador …Equities.comContract awarded for Cyclosporine Supply 50ml 100mg/ml oral solution to Hospital del Salvador. That the hospital del salvador needs to have 100mg/ml cyclosporine su…
Novartis’ Certican succeeds in phase III liver transplant trial
ZURICH (Reuters) – Swiss pharmaceutical company Novartis said on Monday its Certican, an immune system drug also known under the names Afinitor and Votubia, showed positive outcomes in a two-year phase III study in liver transplantation. The study, whi…
SCV Biotech Reports Success in Arthritis Candidate Study – SCVNEWS.com
SCV Biotech Reports Success in Arthritis Candidate StudySCVNEWS.com“In contrast to immunosuppressive drugs, the neuromodulation therapy in this study used an implantable pulse generator to stimulate the vagus nerve, activating the body's natural …